⚠ You're viewing a report from January 2026. Subscribe to get the latest →

FDA Enforcement — January 2026 Report

Automated analysis of 31 items from public government data sources. Updated daily.

Summary

31
Total items
21
High impact
10
Medium impact
0
Low impact

High-impact items this period

Cohance Lifesciences Limited
CGMP violations resulting in adulterated finished pharmaceuticals
Why: Manufacturing process defects or contamination in pharmaceutical production  ·  Jan 30  ·  Impact: HIGH
Diasol, Inc.
Investigational Device Exemption and PMA violations
Why: Non-compliance with IDE requirements or unauthorized device marketing  ·  Jan 29  ·  Impact: HIGH
Central Coast Multispecialty Medical Group, Inc.
HCT/P regulations violations in human cells and tissues handling
Why: Deviations from CFR requirements for cellular and tissue product operations  ·  Jan 29  ·  Impact: HIGH
Beta Bionics, Inc.
Medical device CGMP and Quality System Regulation violations
Why: Manufacturing and quality control failures for adulterated devices  ·  Jan 28  ·  Impact: HIGH
HTO Nevada, Inc. dba Kirkman
CGMP violations resulting in adulterated finished pharmaceuticals
Why: Manufacturing process failures or contamination in pharmaceutical production  ·  Jan 27  ·  Impact: HIGH
Conceive Fertility Center
HCT/P regulations violations in human cells and tissues handling
Why: Deviations from CFR requirements for reproductive tissue operations  ·  Jan 27  ·  Impact: HIGH
Flextronics America LLC
CGMP and QSR violations in medical device manufacturing
Why: Quality system deficiencies in device component production or assembly  ·  Jan 27  ·  Impact: HIGH
Louisville Reproductive Center
HCT/P deviations and CFR regulatory non-compliance
Why: Failure to meet human cells, tissues, and cellular products regulations  ·  Jan 23  ·  Impact: HIGH
Abbott Diabetes Care, Inc.
CGMP and QSR violations in medical device manufacturing
Why: Quality control failures in diabetes monitoring device production  ·  Jan 23  ·  Impact: HIGH
Signature Formulations, LLC
CGMP violations resulting in adulterated finished pharmaceuticals
Why: Manufacturing process failures or quality system deficiencies  ·  Jan 21  ·  Impact: HIGH

Selected medium-impact items

gotpouches.com
Tobacco product misbranding and adulteration violations
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  Jan 30  ·  Impact: MEDIUM
niqpouches.com
Tobacco product misbranding and adulteration violations
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act requirements  ·  Jan 30  ·  Impact: MEDIUM
Fidelity Melon, Inc
Foreign Supplier Verification Program compliance failures
Why: Inadequate verification and monitoring of foreign food suppliers  ·  Jan 29  ·  Impact: MEDIUM
Tombak LLC
Tobacco product adulteration and misbranding violations
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act  ·  Jan 22  ·  Impact: MEDIUM
East CK Trading Inc.
Foreign Supplier Verification Program compliance failures
Why: Inadequate verification procedures for foreign food ingredient suppliers  ·  Jan 16  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →